insights_auto
Why is ARX down 5,71%?
Dive Deeperchevron_right
ARX:ASX
Aroa Biosurgery Ltd
0,50 A$
arrow_downward
-5,71%(-0,030) 1D
1 қаз., 14:52:38 GMT+10 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
0,50 A$
High
0,50 A$
Low
0,49 A$
Mkt. cap
171,22 млн
Avg. vol.
138,96 м.
Volume
298,37 м.
P/E ratio
47,64
52-wk high
0,80 A$
52-wk low
0,48 A$
EPS
0,01 A$
Shares outstanding
345,90 млн
No. of employees
261
Open
0,50 A$
High
0,50 A$
Low
0,49 A$
Mkt. cap
171,22 млн
Avg. vol.
138,96 м.
Volume
298,37 м.
P/E ratio
47,64
52-wk high
0,80 A$
52-wk low
0,48 A$
EPS
0,01 A$
Shares outstanding
345,90 млн
No. of employees
261
News stories
From web sources and news partners
Simply Wall Street
·
30 минут бұрын
Learn Why The Bull Case For Amplitude (AMPL) Could Change Following Earnings Beat
ABC4 Utah
·
1 сағат бұрын
Asian shares mostly rise amid market optimism about AI, despite Iran worries
marketscreener.com
·
1 сағат бұрын
S&P 500 index retreated after the Stockholm exchange closed on Wednesday
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd